Advisors Asset Management Inc. Sells 7,211 Shares of Cardinal Health, Inc. $CAH

Advisors Asset Management Inc. trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 26.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 19,945 shares of the company’s stock after selling 7,211 shares during the period. Advisors Asset Management Inc.’s holdings in Cardinal Health were worth $3,351,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Steward Partners Investment Advisory LLC grew its holdings in Cardinal Health by 2.7% during the second quarter. Steward Partners Investment Advisory LLC now owns 8,707 shares of the company’s stock valued at $1,463,000 after purchasing an additional 228 shares during the period. Clifford Capital Partners LLC lifted its position in shares of Cardinal Health by 3.1% during the 2nd quarter. Clifford Capital Partners LLC now owns 133,793 shares of the company’s stock valued at $22,477,000 after buying an additional 4,078 shares in the last quarter. Insigneo Advisory Services LLC grew its stake in shares of Cardinal Health by 8.4% during the 2nd quarter. Insigneo Advisory Services LLC now owns 2,245 shares of the company’s stock valued at $377,000 after acquiring an additional 174 shares during the period. CreativeOne Wealth LLC increased its holdings in Cardinal Health by 2.5% in the 2nd quarter. CreativeOne Wealth LLC now owns 6,811 shares of the company’s stock worth $1,144,000 after acquiring an additional 167 shares in the last quarter. Finally, Picton Mahoney Asset Management increased its holdings in Cardinal Health by 11.1% in the 2nd quarter. Picton Mahoney Asset Management now owns 114,699 shares of the company’s stock worth $19,271,000 after acquiring an additional 11,415 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

CAH stock opened at $212.26 on Friday. The firm has a fifty day moving average price of $177.57 and a 200 day moving average price of $163.29. Cardinal Health, Inc. has a fifty-two week low of $114.60 and a fifty-two week high of $214.93. The firm has a market cap of $50.43 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. During the same quarter last year, the business earned $1.88 earnings per share. Cardinal Health’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Analysts Set New Price Targets

A number of research firms have weighed in on CAH. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. TD Cowen raised their price target on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Finally, Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.